Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Shares Outstanding (2012 - 2026)

Updated

Inhibitor Therapeutics (INTI) recorded Shares Outstanding of 173.31 million in Q2 2026, up 0.4% from 172.57 million a year earlier and up 0.4% from the prior quarter.

Analysis

Inhibitor Therapeutics (INTI) Shares Outstanding (2012 - 2026) Analysis & Trends

For FY2025, Inhibitor Therapeutics reported Shares Outstanding of 172.51 million, up 0.1% from FY2024.

  • Annual Shares Outstanding has a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding came in at 172.26 million in FY2024 (+0.2%), 171.95 million in FY2023 (-53.0%), 366.18 million in FY2022 (-2.7%) and 376.25 million in FY2021 (+1.2%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding since Q4 2022.
  • On a year-over-year basis, Shares Outstanding has increased for ten consecutive quarters, with growth averaging 0.2% over the last eight quarters.
  • Peak year-over-year performance for Shares Outstanding in the last five years was growth of 1.2% in Q4 2021, against a decline of 54.4% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 172.57 million (Q1 2026), 172.51 million (Q4 2025) and 172.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn - 173.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 173.31 Mn
Mar 31, 2026 172.57 Mn
Dec 31, 2025 172.51 Mn
Sep 30, 2025 172.57 Mn
Jun 30, 2025 172.57 Mn
Mar 31, 2025 172.32 Mn
Dec 31, 2024 172.26 Mn
Sep 30, 2024 172.32 Mn
Jun 30, 2024 172.32 Mn
Mar 31, 2024 172.08 Mn
Dec 31, 2023 171.95 Mn
Sep 30, 2023 172.01 Mn
Jun 30, 2023 171.97 Mn
Mar 31, 2023 171.79 Mn
Dec 31, 2022 366.18 Mn
Sep 30, 2022 376.86 Mn
Jun 30, 2022 376.86 Mn
Mar 31, 2022 376.86 Mn
Dec 31, 2021 376.25 Mn
Sep 30, 2021 376.71 Mn
API Access

Inhibitor Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INTI&period=max&api_key=YOUR_API_KEY